Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
about
Transcriptional Targeting in Cancer Gene TherapyProdrugs for improving tumor targetability and efficiency.The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs.Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity.Impact of tumor blood flow modulation on tumor sensitivity to the bioreductive drug banoxantroneEnhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.How Have Cancer Clinical Trial Eligibility Criteria Evolved Over Time?Gene therapy approaches to enhance bioreductive drug treatment.Radiation enhances the therapeutic effect of Banoxantrone in hypoxic tumour cells with elevated levels of nitric oxide synthase.Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer.Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.
P2860
Q24791038-1B4E72BD-C953-455C-A3CA-DDA5A3785713Q35095165-F32AD6CE-6C60-4FF7-9906-55E0B6515D35Q35967320-EE23A538-C1C9-4E33-A938-1FF24A38F627Q36200146-18A06797-5886-45C6-99F1-D12BFA081C1EQ36573248-C89CCCE4-E19F-470E-8116-4DD8B8BA8EE0Q37037051-3F7901B2-2896-4314-A6CD-6470C738F066Q37211235-FFA3DFBB-676D-4111-84EF-A77D59E471B1Q37280249-61ECE9D6-1DA6-443D-841D-3BAEA090C2BFQ38722296-71976200-D54B-443E-9FF1-06F41DE5FA60Q39916257-A7D117AB-A28C-4581-9CDE-7C4C380A843EQ40330281-9C0C7386-D524-4E70-9C3F-06C750240E10
P2860
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
@en
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
@nl
type
label
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
@en
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
@nl
prefLabel
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
@en
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
@nl
P2093
P2860
P356
P1433
P1476
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
@en
P2093
Anita Yakkundi
Ciara M Hughes
David G Hirst
Gillian Keilty
Helen O McCarthy
Laurence H Patterson
Margaret Murray
Stephanie R McKeown
Verna McErlane
P2860
P2888
P356
10.1038/SJ.CGT.7700522
P50
P577
2003-01-01T00:00:00Z